Coya Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
3.67 |
4.25 |
1.70 |
12.50 |
25.00 |
30.68 |
| Przychód Δ r/r |
0.00% |
15.98% |
-60.03% |
635.29% |
100.00% |
22.70% |
| Przychód (min) |
3.59 |
3.09 |
1.70 |
4.40 |
8.81 |
10.81 |
| Przychód (max) |
3.74 |
5.41 |
1.70 |
22.17 |
44.34 |
54.40 |
| EBITDA (średnia) |
0.73 |
0.85 |
0.34 |
2.50 |
5.00 |
6.14 |
| EBIT (średnia) |
0.73 |
0.85 |
0.34 |
2.50 |
5.00 |
6.14 |
| EBIT % |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
| Zysk netto (średni) |
-16.69 |
-24.80 |
-29.40 |
-28.22 |
-20.73 |
-21.94 |
| Zysk netto % |
-454.99% |
-583.13% |
-1729.16% |
-225.78% |
-82.90% |
-71.54% |
| EPS (średnia) |
-1.09 |
-1.63 |
-1.95 |
-1.58 |
-1.36 |
-1.44 |
| Liczba analityków (Przychody) |
4 |
4 |
7 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
2 |
5 |
3 |
1 |
1 |
| symbol |
COYA |
COYA |
COYA |
COYA |
COYA |
COYA |